Genetic features and the redundancy phenomenon
For a long time, the study of primary immunodeficiencies was viewed as observing "experiments of nature." Today, to understand their pathogenesis, the spectrum of human gene disruptions is compared with the results of creating laboratory "knockout" mice (animals with artificially deactivated genes).
A crucial feature of the immune system is the redundancy phenomenon. Many functions (such as cytokine effects) can be performed by several different molecules. If a mutation turns off one gene, others take over its work, and the clinical defect does not manifest at all. Therefore, severe phenotypic manifestations occur only when mutations affect genes responsible for absolutely essential molecules.
Interestingly, in humans, the spectrum of congenital immunodeficiencies is much narrower than the set of mutations that can be artificially induced in mice in the laboratory. This is explained by two factors:
- Embryonic lethality. If the genetic defect affects not only lymphocytes but also vital tissues (such as the myeloid lineage), the fetus dies in utero. This is why we do not encounter isolated congenital defects of the myeloid lineage.
- Natural selection. Obviously deleterious mutations are rapidly eliminated from the population.
Levels of impairment and classic syndromes
The spectrum of lymphoid immunodeficiencies clearly reflects the stages of normal lymphocyte maturation. The traditional division into cellular, humoral, and combined forms is now considered outdated, as isolated disorders are practically non-existent due to the close interconnection of the immune branches.
The main groups of disorders are linked to the stages of cell differentiation:
- Disorders of early precursors: Defects in the rearrangement of antigen-recognizing receptors (mutations in RAG-1 and RAG-2 recombinases) or cytokine receptors (mutation of the common γ(c)-chain). These lead to severe combined immunodeficiency (SCID), which blocks the development of both T and B lineages.
- T-cell development defects: Include DiGeorge syndrome (disruption of the thymic microenvironment) and defects in subpopulation differentiation (e.g., defects in ZAP-70 or TAP molecules, leading to the absence of CD8+ T cells).
- B-cell development disorders: A classic example is Bruton agammaglobulinemia. It develops due to a block in signal transduction from the pre-BCR receptor, which prevents B lymphocytes from continuing maturation.
- Defects at the mature cell level: Problems with immunoglobulin isotype switching cause hyper-IgM syndrome (often due to a mutation in the co-stimulatory molecule CD154) or selective deficiencies (IgA deficiency).
- Disorders of suppressor mechanisms: Lead to autoimmune pathology due to a defect in the elimination of autospecific lymphocyte clones (e.g., IPEX syndrome, affecting regulatory T cells).
Clinical presentation
Regardless of the specific mutation, the basis of the clinical picture is always impaired resistance to pathogens. The primary targets of infection in this case are barrier tissues (mucous membranes of the respiratory tract, ENT organs, gastrointestinal tract, and skin).
Dependence of pathogens on the damaged link:
- B-cell and complement defect — vulnerability to extracellular bacteria.
- Decreased CD4+ T-cell function — susceptibility to intracellular pathogens residing in macrophage vesicles.
- CD8+ and NK-cell deficiency — inability to destroy pathogens that have penetrated the cytosol or genome (viruses).
In addition to recurrent infections, many primary immunodeficiencies are characterized by a triad of aggravating syndromes: severe allergies (especially in hyper-IgE syndrome), multiple autoimmune reactions, and a high incidence of malignant lymphoproliferative tumors (e.g., in Wiskott-Aldrich syndrome or ataxia-telangiectasia).
Diagnostic Principles
Routine counting of lymphocyte numbers in the bloodstream is only useful in the most severe forms where cell development is completely blocked (SCID, Bruton's agammaglobulinemia). In most cases, however, lymphocytes may be present in normal numbers while being functionally incompetent.
Modern diagnostics necessarily include:
- Evaluation of specific molecule expression: checking membrane CD154, immunoglobulin class levels, and complement component activity.
- Molecular genetic methods: using PCR to identify specific defective genes (e.g., btk, ZAP-70, Fas, FOXP3) and determine the nature of the mutation itself (deletion, missense mutation).
Briefly: answers to topical questions
What mutations cause severe combined immunodeficiency (SCID)?
Severe combined immunodeficiency (SCID) is caused by mutations that disrupt lymphocyte development at the common progenitor level or during early stages of differentiation. These include:
- γ(c)-chain deficiency — a mutation in the common structural subunit of cytokine receptors, leading to the death of early precursors.
- IL-7 receptor α-chain deficiency — causes apoptosis of progenitor cells due to a lack of proliferation stimuli.
- Recombinase defects (RAG-1, RAG-2) — disrupt the initiation of V-gene rearrangement.
- DNA-dependent protein kinase mutation — impedes the execution of intermediate stages of gene rearrangement.
- Enzyme deficiencies — absence of adenosine deaminase (ADA) or purine nucleoside phosphorylase (PNP), leading to the accumulation of toxic metabolites.
What is the mechanism of development of Bruton's agammaglobulinemia?
The mechanism of Bruton's agammaglobulinemia involves a block in B-lymphocyte maturation due to impaired intracellular signaling. The pathology arises from a mutation in the Btk gene located on the X chromosome. This gene encodes the Btk protein kinase, which is normally required to transmit activation signals from the intermediate pre-BCR receptor. Deficiency of this enzyme leads to a complete arrest of B-lymphocyte differentiation at the pre-B cell stage (pro-BII). As a result, mature B cells, plasma cells, and immunoglobulin receptors are absent in the body, causing a severe humoral immunity disorder.
Mutations in which genes cause hyper-IgM syndrome?
Hyper-IgM syndrome develops due to mutations in genes responsible for intercellular interaction and antibody isotype switching. These include:
- The TNFSF5 gene (encoding CD154 or CD40L) — its defect causes the X-linked variant HIGM1, disrupting the contact between T lymphocytes and antigen-presenting cells.
- The CD40 receptor gene — mutation blocks interaction with the CD154 ligand.
- The IKKγ molecule gene — mutation leads to a syndrome combined with anhidrotic ectodermal dysplasia.
- The gene for the AID enzyme (activation-induced cytidine deaminase) — mutation causes the autosomal recessive form HIGM2, disrupting heavy chain isotype switching and hypermutation.
In which primary immunodeficiencies are malignant lymphoproliferative tumors common?
Malignant lymphoproliferative tumors are common in the following primary immunodeficiencies:
- Ataxia-telangiectasia — an immunodeficiency combined with chromosomal instability. Specific translocations (e.g., translocation of a fragment containing the TCL1 gene to T-cell receptor genes) lead to the development of T-cell leukemia.
- X-linked lymphoproliferative syndrome — characterized by a high probability of B-cell infection with the Epstein-Barr virus due to a defect in the SH2D1A gene. One of the most consistent signs of the disease is the development of benign and malignant lymphoproliferative disorders.
What primary immunodeficiencies of the phagocytic link (myeloid lineage) exist?
Primary immunodeficiencies caused by impaired myeloid cell differentiation do not exist, as such mutations lead to intrauterine fetal death. However, genetic defects of innate immunity at the stage of phagocyte effector function execution do occur:
- Chronic granulomatous disease is associated with a defect in bactericidal factor enzymes (e.g., NADPH oxidase).
- LAD syndrome is caused by a defect in adhesion molecules necessary for cell migration.
- Chediak-Higashi syndrome arises due to impaired mechanisms of intracellular granule release.
- Neutropenias include cyclic and congenital X-linked neutropenia.
Which primary immunodeficiencies develop due to impaired suppressor mechanisms?
Impaired suppressor (regulatory) mechanisms lead to syndromes with immune dysregulation, in which control over autoreactive clones is compromised:
- IPEX syndrome occurs due to a mutation in the FOXP3 gene, which blocks the development of natural regulatory T cells (Treg) that restrain autospecific clones.
- Autoimmune lymphoproliferative syndrome (ALPS) is associated with defects in the Fas receptor, Fas ligand, or caspases 8 and 10. This impairs receptor-mediated apoptosis and the elimination of autospecific lymphocytes.
- APECED syndrome is caused by a mutation in the AIRE gene, which disrupts the expression of organ-specific antigens in the thymus and impairs negative T-cell selection.
Similar disorders also occur with mutations in the IL-2 gene, its receptors, TGFβ, CTLA-4, and PD-1.
To connect the immune component with pathogen localization, remember: B cells defend the "street" (extracellular environment), CD4+ inspect "storage lockers" (vesicles), and CD8+ and NK cells clear out the "headquarters" (cytosol and cell nucleus).
What else to study on this topic
- Gene knockout technology and marker genes (neo, HSV-tk)
- Disorders of V gene recombination mechanisms (the role of RAG-1 and RAG-2 genes)
- Pathogenesis of DiGeorge syndrome and thymic dysgenesis
- Mechanism of hyper-IgM syndrome development (the role of CD40 and CD154 molecules)
- Apoptosis disorders in autoimmune lymphoproliferative syndrome (ALPS)
Master the entire topic in the "Immunology" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Primary Immunodeficiencies" and 723 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 23 video lessons on the subject
Other topics in the section "Immunity in defense and damage of the organism. Pathology of immunity"
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.